Search research articles
Contact Us
Filters
Showing results (1-10 of 62) with videos related to
Page
of 7
Sort By:
Hepatology Communications
|
July 12, 2022
Response to immunotherapy plus anti-angiogenic agent combination challenges hepatocellular carcinoma prognostic scores
Xavier Adhoute, Thomas Wolf
La Revue Du Praticien
|
March 15, 2019
[Hepatitis B virus infection: control or cure?]
Marc Bourlière, Valérie Oules, Xavier Adhoute
Annals of Translational Medicine
|
August 9, 2024
COSMIC-312, a disappointing result-is that so surprising?
Xavier Adhoute, Marc Bourlière, Rodolphe Anty
Translational Gastroenterology and Hepatology
|
January 23, 2018
Impact of direct-acting antiviral agents on the risk for hepatocellular carcinoma
Xavier Adhoute, Paul Castellani, Marc Bourlière
Annals of Translational Medicine
|
January 13, 2021
Transarterial chemoembolization (TACE) plus sorafenib: a real winning combination?
Xavier Adhoute, Rodolphe Anty, Marc Bourlière
The Lancet. Gastroenterology & Hepatology
|
June 27, 2017
To TACE or not to TACE? Lessons from a negative trial
Jean-Luc Raoul, Marine Gilabert, Xavier Adhoute
Liver International : Official Journal of the International Association for the Study of the Liver
|
March 10, 2020
ALBI-based BCLC nomogram: A new or an additional prognostic tool?
Xavier Adhoute, Edouard Larrey, Guillaume Pénaranda, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
January 19, 2016
Staging of hepatocellular carcinoma: BCLC system, what else!
Xavier Adhoute, Guillaume Penaranda, Jean Luc Raoul, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
November 10, 2019
Prognostication of HCC under sorafenib: Is it always possible?
Xavier Adhoute, Guillaume Pénaranda, Jean-Luc Raoul, et al.
Journal of Hepatology
|
September 14, 2019
The "six-and-twelve score" for TACE treatment: Does it really help us?
Marc Bourlière, Guillaume Pénaranda, Xavier Adhoute, et al.
Page
of 7
Search research articles
Search
Showing results (1-10 of 62) with videos related to
Sort By:
Page
of 7
Hepatology Communications
|
July 12, 2022
Response to immunotherapy plus anti-angiogenic agent combination challenges hepatocellular carcinoma prognostic scores
Xavier Adhoute, Thomas Wolf
La Revue Du Praticien
|
March 15, 2019
[Hepatitis B virus infection: control or cure?]
Marc Bourlière, Valérie Oules, Xavier Adhoute
Annals of Translational Medicine
|
August 9, 2024
COSMIC-312, a disappointing result-is that so surprising?
Xavier Adhoute, Marc Bourlière, Rodolphe Anty
Translational Gastroenterology and Hepatology
|
January 23, 2018
Impact of direct-acting antiviral agents on the risk for hepatocellular carcinoma
Xavier Adhoute, Paul Castellani, Marc Bourlière
Annals of Translational Medicine
|
January 13, 2021
Transarterial chemoembolization (TACE) plus sorafenib: a real winning combination?
Xavier Adhoute, Rodolphe Anty, Marc Bourlière
The Lancet. Gastroenterology & Hepatology
|
June 27, 2017
To TACE or not to TACE? Lessons from a negative trial
Jean-Luc Raoul, Marine Gilabert, Xavier Adhoute
Liver International : Official Journal of the International Association for the Study of the Liver
|
March 10, 2020
ALBI-based BCLC nomogram: A new or an additional prognostic tool?
Xavier Adhoute, Edouard Larrey, Guillaume Pénaranda, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
January 19, 2016
Staging of hepatocellular carcinoma: BCLC system, what else!
Xavier Adhoute, Guillaume Penaranda, Jean Luc Raoul, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
November 10, 2019
Prognostication of HCC under sorafenib: Is it always possible?
Xavier Adhoute, Guillaume Pénaranda, Jean-Luc Raoul, et al.
Journal of Hepatology
|
September 14, 2019
The "six-and-twelve score" for TACE treatment: Does it really help us?
Marc Bourlière, Guillaume Pénaranda, Xavier Adhoute, et al.
Page
of 7